Fact CheckerSign in

NCT04814212RecruitingPhase 4

Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI

Source: ClinicalTrials.gov · Last updated 9 Nov 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of this study is to compare DCB with DES in stable CAD or ACS patients who are at high risk of bleeding. The hypothesis of the DEBATE trial is that the strategy using DCB and a shorter DAPT regimen is non-inferior to the treatment using DES and longer DAPT duration on patients with high bleeding risk. If non-inferiority is shown, the superiority of the DCB strategy over DES strategy will be tested.

Status (registry)
Recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
546 (estimated)
First submitted
22 Mar 2021
Start date
1 Sept 2022
Primary completion date
1 Jan 2026
Lead sponsor
North Karelia Central Hospital
NCT number
NCT04814212
EU CT number
2023-504340-34-01

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 546
  • From 1 Sept 2022 to the primary completion date, 1 Jan 2026
  • 13 sites in 5 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Need for bypass surgery by heart team decision

Other

  • Inability to give written consent
  • STEMI
  • Reference diameter of the vessel is \<2.0mm or \>5.0 mm
  • Bifurcation lesion requiring the stenting of either of the branches after predilatation (TIMI\<3 or significant recoil \>30% in the main epicardial vessel: LAD, LCX or RCA) after predilatation)
  • Dissection affecting the flow (TIMI\<3) or significant recoil (\>30% in the main epicardial vessel: LAD, LCX or RCA) after predilatation
  • in-stent restenosis
  • Chronic total occlusion
  • Life expectancy \< 12 months
  • Cardiogenic shock at the arrival to the coronary angiography
  • Uncertainty about neurological recovery e.g. after resuscitation

Who the study is looking for

  • Age ≥ 18 years
  • Informed written consent
  • At least one major or two minor bleeding risk criteria of Academic Research Consortium (ARC)
    • Major Criteria
  • Long-term oral anticoagulation
  • Severe or end stage chronic kidney disease (CKD) (estimated glomerular - filtration rate \[eGFR\] \<30 ml/min)
  • Hemoglobin \<110 g/l
  • Spontaneous bleeding requiring hospitalization and transfusion in the past 6 months
  • Moderate to severe baseline thrombocytopenia (platelet count \<100 x 10e9/L)
  • Chronic bleeding diathesis
  • Liver cirrhosis with portal hypertension
  • Active cancer in the past 12 months
  • Previous spontaneous ICH (at any time)
  • Previous traumatic ICH within the past 12 months
  • Presence of known brain arteriovenous malformation
  • Moderate to severe ischemic stroke within the past 6 months
  • Nondeferrable major surgery on dual antiplatelet therapy
  • Recent major surgery or trauma within 30 days before PCI
    • Minor Criteria
  • Age \>75 years
  • Moderate CKD (eGFR 30-59 ml/min)
  • Hemoglobin 110-129 g/l for men and 110-119 g/l for women
  • Spontaneous bleeding requiring hospitalization or transfusion within the past 12 - months not meeting major criterion
  • Long term use of oral nonsteroidal antiinflammatory drugs or steroids
  • Any ischemic stroke at any time not meeting major criterion
    • Either of the following:
  • Stabile angina or dyspnea and a coronary narrowing causing myocardial ischemia detected in the angiogram. In stable patients prior PCI, the evidence of ischemia is needed acquired either by perfusion imaging or by pressure wire measurement (FFR) during coronary angiography unless the coronary stenosis is \> 90% in diameter.
  • ACS (UAP or NSTEMI): symptoms of heart ischemia≥ 20 minutes and ≥ 0,5mm ST-depression or transient ST-elevation or T-wave inversion at least in two adjacent leads and/or a high sensitivity troponin (hs-tnt) rise at least one unit above the 99. percentil or at least 50% rise in hs-tnt between two samples taken 1-3 hours apart.
    • At least one of the following:
  • ≥1 de novo lesions in native coronary arteries or bypass vein grafts
  • Reference diameter of the vessel is 2.0-5.0mm'
  • Lesion length ≤ 40mm
  • Lesion or lesions are suitable for PCI

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (13)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital of Carl Gustav Carus
Coordinator of this site? Confirm its status
DresdenGermanyNot yet recruiting
UniversitY Hospital of Saarland
Coordinator of this site? Confirm its status
HomburgGermanyNot yet recruiting
Hospital Universitario de Cabueñes
Coordinator of this site? Confirm its status
GijónSpainRecruiting
Hospital Alvaro Cunqueiro
Coordinator of this site? Confirm its status
VigoSpainRecruiting
Helsinki University Central Hospital
Coordinator of this site? Confirm its status
HelsinkiFinlandRecruiting
Wellbeing Services County Of North Karelia Siun Sote
Coordinator of this site? Confirm its status
JoensuuFinlandRecruiting
Central Finland Hospital District Central Finland Hospital Nova
Coordinator of this site? Confirm its status
JyvaskylaFinlandRecruiting
University Of Kuopio
Coordinator of this site? Confirm its status
KuopioFinlandRecruiting
TAYS Sydaenkeskus Oy
Coordinator of this site? Confirm its status
TampereFinlandRecruiting
Turku University Hospital
Coordinator of this site? Confirm its status
TurkuFinlandRecruiting
Centre Hospitalier Groupe Hospitalier De La Rochelle Re Aunis
Coordinator of this site? Confirm its status
La RochelleFranceRecruiting
Paris - Hôpital Cochin
Coordinator of this site? Confirm its status
ParisFranceRecruiting
Norfolk and Norwich University Hospital Nhs Foundation Trust
Coordinator of this site? Confirm its status
NorwichUnited KingdomNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.